UBS Group’s Cytek Biosciences CTKB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$817K Sell
186,881
-273,166
-59% -$1.29M ﹤0.01% 5707
2025
Q4
$2.32M Sell
460,047
-8,642
-2% -$40.1K ﹤0.01% 4831
2025
Q3
$1.63M Sell
468,689
-163,363
-26% -$613K ﹤0.01% 5156
2025
Q2
$2.15M Buy
632,052
+20,524
+3% +$68.4K ﹤0.01% 4748
2025
Q1
$2.45M Sell
611,528
-54,205
-8% -$281K ﹤0.01% 4530
2024
Q4
$4.32M Buy
665,733
+646,789
+3,414% +$3.85M ﹤0.01% 3986
2024
Q3
$105K Sell
18,944
-60,588
-76% -$344K ﹤0.01% 6319
2024
Q2
$444K Sell
79,532
-3,375
-4% -$20.3K ﹤0.01% 5088
2024
Q1
$556K Buy
82,907
+82,885
+376,750% +$656K ﹤0.01% 5113
2023
Q4
$201 Sell
22
-595
-96% -$3.75K ﹤0.01% 8813
2023
Q3
$3.41K Sell
617
-231,992
-100% -$1.86M ﹤0.01% 7562
2023
Q2
$1.99M Buy
232,609
+155,295
+201% +$1.39M ﹤0.01% 3533
2023
Q1
$711K Buy
77,314
+32,198
+71% +$346K ﹤0.01% 4407
2022
Q4
$461K Buy
45,116
+41,103
+1,024% +$552K ﹤0.01% 4775
2022
Q3
$59K Buy
4,013
+3,950
+6,270% +$51.3K ﹤0.01% 6175
2022
Q2
$1K Buy
+63
New +$627 ﹤0.01% 9840
2021
Q4
Sell
-831
Closed -$18K 10316
2021
Q3
$18K Buy
+831
New +$19.5K ﹤0.01% 7270

Other funds holding CTKB